Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by American Cyanamid CofiledCriticalAmerican Cyanamid Co
Priority to KR7403273ApriorityCriticalpatent/KR790000357B1/en
Application grantedgrantedCritical
Publication of KR790000357B1publicationCriticalpatent/KR790000357B1/en
16α, 17α(cyclopentylidenedloxy)-9-fluoro11β, 21-dihydroxypregna-1, 4-diene-3, 20-dione-21-acetate, an effective antiinflammatory compd., was prepd. by reaction of triamcinolone with HC103 and cyclopentanone followed by treatment with pyridine and acetic anhydride. Formulations for antiinflammatory creams, ointments, and lotions contg. this compd. were reported.
KR7403273A1974-08-051974-08-05Process for preparation of an anti-inflamatory composition
KR790000357B1
(en)